
Bristows' Podcast
Never content to do the bare minimum, we've always been at the forefront of change. You could say we are and always have been a bit different from other law firms. Our legal expertise joined up with our science and technology backgrounds means we understand your business and can talk the same language. And that's essentially what we cover in this podcast. A truly independent approach to litigation, transactions and advice throughout the world.
Episodes
63 episodes
Navigating the challenges of investing in or acquiring companies utilising Agentic AI
In the second episode of our series exploring Corporate Law and AI, our experts, Partner Iain Redford (Corporate & Tax) and Partner
•
Episode 2
•
9:43

Navigating the Future - Corporate Law and AI - Recognising value in AI transactions
In the first episode of our series exploring Corporate Law and AI, our experts, Partner Vik Khurana (Commercial Technology) and Of Counsel
•
Season 1
•
Episode 1
•
18:40

Rapid reaction: CJEU clarifies jurisdictional issues in cross-border patent disputes
Following the CJEU’s landmark decision in the BSH v Electrolux case (C-339/22), patent litigators Andrew Bowler and Gregory Bacon discuss the three questions referred by the Swedish Court of Appeal to the European court.Explore our more ...
•
25:16

Biotech Review of the Year: Six months on
It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication.
•
11:33

Tech M&A series - Acquihire deals - key considerations and potential pitfalls
In this episode our experts Iain Redford (corporate), Miranda Cass (tax) and
•
Episode 4
•
15:03

Tech M&A series - Adtech M&A
In this episode of Tech M&A, our experts, Jamie Drucker and Richard Swaine look at the regulatory challenges ...
•
21:26

Tech M&A series - Trends in Medtech M&A
In this episode of Tech M&A, our experts, Sophie Rees and Jamie Hatzel discuss some of the recent trends affectin...
•
13:23

Ep 3: Full Disclosure - the Statutory Disclosure Regime and the medtech sector
Chris Bates and Jamie Hatzel round out this three-part series with a discussion of the likely impact of the Statutory Disclosure Regime proposals on the medtech sector, and how medtech will have to play catch-up to remain compliant once the Sta...
•
5:58

Ep 2: Full Disclosure - the Statutory Disclosure Regime proposals in detail
Jamie Hatzel and Vivien Zhu delve into some of the finer details of the Statutory Disclosure Regime proposals, including the scope of the proposed regime and the role that voluntary disclosure schemes could continue to play once the regime come...
•
13:53

Ep 1: Full Disclosure - Introducing the Statutory Disclosure Regime consultation
Chris Bates and Vivien Zhu introduce the UK government’s consultation on a statutory regime for disclosure of transfers of value to the healthcare sector by the life sciences industry. Chris talks about the historical context of voluntary schem...
•
Episode 1
•
8:41

Tech M&A series - Generative AI
In this episode, experts Chris Devlin and Julia Cockroft explore the impact the National Security and Investmen...
•
23:39

InterDigital v Lenovo - Initial impressions
In this episode, Luke Maunder discusses the long-awaited FRAND judgment of Mr Justice Mellor with special guest star Dr Myles Jelf. Luke and Myles delve into the decision and set out the key information you need to know.
•
23:50

Free-standing FRAND actions green lit
In this quick update, senior associates and IP specialists Luke Maunder and Naomi Hazenberg discuss the recent decision in Kigen v Thales, which considers the jurisdiction of the court for a claim that included FRAND declarations that wer...
•
10:42

FRAND injunctions and undertakings
Senior associates and IP specialists Luke Maunder and Naomi Hazenberg discuss the development of the English FRAND injunction and the timing of when an undertaking to enter a FRAND licence is required.
•
21:59

FRAND methodologies before the British Courts
Senior associates and IP specialists Luke Maunder and Naomi Hazenberg go back to the future to look at FRAND meth...
•
17:22

How have British Courts treated patent pools?
Senior associates and IP specialists, Luke Maunder and Naomi Hazenberg, look at how the British Courts have...
•
13:18

Disclosure & confidentiality: “If only we could have a little more transparency”
"If only we could have a little more transparency" is a refrain heard by every licensor, but commercial sensitivities and confidentiality obligations/concerns abound in the FRAND space. Senior associates and IP specialists,
•
19:37

Jurisdiction: Where are we now?
Senior associates and IP specialists Luke Maunder and Naomi Hazenberg briefly recap the history of jurisdiction c...
•
16:01
